{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:22:44Z","timestamp":1781299364545,"version":"3.54.1"},"reference-count":221,"publisher":"Elsevier","isbn-type":[{"value":"9780128240304","type":"print"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.acr.2020.10.003","type":"book-chapter","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T09:08:29Z","timestamp":1605517709000},"page":"103-142","source":"Crossref","is-referenced-by-count":39,"title":["Hepatitis C virus associated hepatocellular carcinoma"],"prefix":"10.1016","member":"78","reference":[{"issue":"6","key":"10.1016\/bs.acr.2020.10.003_bb0010","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1872-034X.2011.00953.x","article-title":"Hepatitis C virus core protein upregulates the expression of vascular endothelial growth factor via the nuclear factor-kappaB\/hypoxia-inducible factor-1alpha axis under hypoxic conditions","volume":"42","author":"Abe","year":"2012","journal-title":"Hepatology Research"},{"issue":"5","key":"10.1016\/bs.acr.2020.10.003_bb0015","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2004.12.034","article-title":"An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation","volume":"42","author":"Abid","year":"2005","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1016\/bs.acr.2020.10.003_bb0020","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/hep.20719","article-title":"NAD(P)H oxidase plays a crucial role in PDGF-induced proliferation of hepatic stellate cells","volume":"41","author":"Adachi","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/bs.acr.2020.10.003_bb0025","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.it.2019.04.001","article-title":"Long noncoding RNAs in host-pathogen interactions","volume":"40","author":"Agliano","year":"2019","journal-title":"Trends in Immunology"},{"key":"10.1016\/bs.acr.2020.10.003_bb0030","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/s12879-014-0632-y","article-title":"Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia","volume":"14","author":"Al-Anazi","year":"2014","journal-title":"BMC Infectious Diseases"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb0035","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.clinre.2017.06.004","article-title":"Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma","volume":"41","author":"Ali","year":"2017","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"issue":"9972","key":"10.1016\/bs.acr.2020.10.003_bb0040","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","article-title":"Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)","volume":"385","author":"Allemani","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/dbio.1999.9534","article-title":"Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development","volume":"217","author":"Arthur","year":"2000","journal-title":"Developmental Biology"},{"issue":"3","key":"10.1016\/bs.acr.2020.10.003_bb0050","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ncrna.2018.03.001","article-title":"Exploring the mechanisms behind long noncoding RNAs and cancer","volume":"3","author":"Balas","year":"2018","journal-title":"Noncoding RNA Research"},{"issue":"14","key":"10.1016\/bs.acr.2020.10.003_bb0055","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1128\/JVI.00619-16","article-title":"Hepatitis C virus-induced upregulation of microRNA miR-146a-5p in hepatocytes promotes viral infection and deregulates metabolic pathways associated with liver disease pathogenesis","volume":"90","author":"Bandiera","year":"2016","journal-title":"Journal of Virology"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0060","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2014.10.004","article-title":"miR-122--a key factor and therapeutic target in liver disease","volume":"62","author":"Bandiera","year":"2015","journal-title":"Journal of Hepatology"},{"issue":"12","key":"10.1016\/bs.acr.2020.10.003_bb0065","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/infdis\/jir186","article-title":"Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture","volume":"203","author":"Bandyopadhyay","year":"2011","journal-title":"The Journal of Infectious Diseases"},{"issue":"9","key":"10.1016\/bs.acr.2020.10.003_bb0070","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1128\/JVI.02449-10","article-title":"Transcriptional repression of C4 complement by hepatitis C virus proteins","volume":"85","author":"Banerjee","year":"2011","journal-title":"Journal of Virology"},{"issue":"12","key":"10.1016\/bs.acr.2020.10.003_bb0075","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1128\/JVI.02344-09","article-title":"Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression","volume":"84","author":"Banerjee","year":"2010","journal-title":"Journal of Virology"},{"issue":"9","key":"10.1016\/bs.acr.2020.10.003_bb0080","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.3390\/v2092108","article-title":"Oncogenic potential of hepatitis C virus proteins","volume":"2","author":"Banerjee","year":"2010","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb0085","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1073\/pnas.94.4.1200","article-title":"Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets","volume":"94","author":"Barba","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb0095","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2009.05.008","article-title":"Hepatitis C virus-induced hepatocarcinogenesis","volume":"51","author":"Bartosch","year":"2009","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.2002.1460","article-title":"Hepatitis C virus core protein is necessary for the maintenance of immortalized human hepatocytes","volume":"298","author":"Basu","year":"2002","journal-title":"Virology"},{"issue":"9","key":"10.1016\/bs.acr.2020.10.003_bb0105","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1172\/JCI18212","article-title":"NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis","volume":"112","author":"Bataller","year":"2003","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12916-017-0815-7","article-title":"Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals","volume":"15","author":"Baumert","year":"2017","journal-title":"BMC Medicine"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0115","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.yexcr.2018.09.023","article-title":"CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer","volume":"372","author":"Benkheil","year":"2018","journal-title":"Experimental Cell Research"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0120","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajpath.2015.10.003","article-title":"Serum miR-30e and miR-223 as novel noninvasive biomarkers for hepatocellular carcinoma","volume":"186","author":"Bhattacharya","year":"2016","journal-title":"The American Journal of Pathology"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062581","article-title":"Hepatitis C virus NS2 protein inhibits DNA damage pathway by sequestering p53 to the cytoplasm","volume":"8","author":"Bittar","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/bs.acr.2020.10.003_bb0130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.aogh.2014.09.008","article-title":"Cancer in low- and medium-income countries","volume":"80","author":"Boffetta","year":"2014","journal-title":"Annals of Global Health"},{"issue":"11","key":"10.1016\/bs.acr.2020.10.003_bb0135","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1128\/JVI.00050-12","article-title":"Hepatitis C virus activates the mTOR\/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance","volume":"86","author":"Bose","year":"2012","journal-title":"Journal of Virology"},{"issue":"6","key":"10.1016\/bs.acr.2020.10.003_bb0140","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"Suppl 1","key":"10.1016\/bs.acr.2020.10.003_bb0145","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0168-8278(12)60007-5","article-title":"The interaction of metabolic factors with HCV infection: Does it matter?","volume":"56","author":"Bugianesi","year":"2012","journal-title":"Journal of Hepatology"},{"issue":"28","key":"10.1016\/bs.acr.2020.10.003_bb0150","first-page":"9261","article-title":"Cytokinome profile evaluation in patients with hepatitis C virus infection","volume":"20","author":"Capone","year":"2014","journal-title":"World Journal of Gastroenterology"},{"issue":"5","key":"10.1016\/bs.acr.2020.10.003_bb0155","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jhep.2016.07.027","article-title":"High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis","volume":"65","author":"Cardoso","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"7","key":"10.1016\/bs.acr.2020.10.003_bb0160","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.15252\/embr.201541763","article-title":"Long noncoding RNA EGOT negatively affects the antiviral response and favors HCV replication","volume":"17","author":"Carnero","year":"2016","journal-title":"EMBO Reports"},{"issue":"3","key":"10.1016\/bs.acr.2020.10.003_bb0165","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1572-0241.2005.40898.x","article-title":"Hepatitis C virus-induced hepatocellular steatosis","volume":"100","author":"Castera","year":"2005","journal-title":"The American Journal of Gastroenterology"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb0170","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jhep.2016.06.019","article-title":"Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis","volume":"65","author":"Cheung","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb0175","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF02355056","article-title":"Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis","volume":"31","author":"Chiba","year":"1996","journal-title":"Journal of Gastroenterology"},{"issue":"11","key":"10.1016\/bs.acr.2020.10.003_bb0180","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1074\/jbc.M512438200","article-title":"Modulation of the transforming growth factor-beta signal transduction pathway by hepatitis C virus nonstructural 5A protein","volume":"281","author":"Choi","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/bs.acr.2020.10.003_bb0185","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1158\/1055-9965.EPI-09-1297","article-title":"Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: A meta-analysis","volume":"19","author":"Chuang","year":"2010","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0190","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.canlet.2004.06.045","article-title":"Expression of c-kit protooncogene in human hepatocellular carcinoma","volume":"217","author":"Chung","year":"2005","journal-title":"Cancer Letters"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0195","first-page":"13","article-title":"Long non-coding RNAs in multifactorial diseases: Another layer of complexity","volume":"4","author":"Cipolla","year":"2018","journal-title":"Noncoding RNA"},{"issue":"596","key":"10.1016\/bs.acr.2020.10.003_bb0200","doi-asserted-by":"crossref","first-page":"F28","DOI":"10.1111\/ecoj.12420","article-title":"The effects of two influential early childhood interventions on health and healthy behaviour","volume":"126","author":"Conti","year":"2016","journal-title":"Economic Journal"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0205","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbrc.2015.12.101","article-title":"Long non-coding RNA PVT1 and cancer","volume":"471","author":"Cui","year":"2016","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0210","article-title":"Functional interplay between RNA viruses and non-coding RNA in mammals","volume":"5","author":"Damas","year":"2019","journal-title":"Noncoding RNA"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2036.2006.02729.x","article-title":"Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection","volume":"23","author":"de Gottardi","year":"2006","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb0220","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/hep.27969","article-title":"World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma","volume":"62","author":"de Martel","year":"2015","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/bs.acr.2020.10.003_bb0225","doi-asserted-by":"crossref","first-page":"8556","DOI":"10.1128\/JVI.00146-11","article-title":"Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway","volume":"85","author":"Deng","year":"2011","journal-title":"Journal of Virology"},{"issue":"6","key":"10.1016\/bs.acr.2020.10.003_bb0230","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02225-16","article-title":"Exosome-mediated intercellular communication between hepatitis C virus-infected hepatocytes and hepatic stellate cells","volume":"91","author":"Devhare","year":"2017","journal-title":"Journal of Virology"},{"key":"10.1016\/bs.acr.2020.10.003_bb0235","doi-asserted-by":"crossref","first-page":"357204","DOI":"10.1155\/2009\/357204","article-title":"Peroxisome proliferator-activated receptors in HCV-related infection","volume":"2009","author":"Dharancy","year":"2009","journal-title":"PPAR Research"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0240","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1053\/j.gastro.2004.11.016","article-title":"Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection","volume":"128","author":"Dharancy","year":"2005","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/bs.acr.2020.10.003_bb0245","first-page":"2060","article-title":"Hepatitis C-related hepatocellular carcinoma in the United States: Influence of ethnic status","volume":"98","author":"Di Bisceglie","year":"2003","journal-title":"The American Journal of Gastroenterology"},{"issue":"8981","key":"10.1016\/bs.acr.2020.10.003_bb0250","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0140-6736(95)91691-1","article-title":"Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection","volume":"346","author":"Diepolder","year":"1995","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/bs.acr.2020.10.003_bb0255","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/hep.510260308","article-title":"Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: A case-control study in Italy. Brescia HCC study","volume":"26","author":"Donato","year":"1997","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb0260","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/aje\/155.4.323","article-title":"Alcohol and hepatocellular carcinoma: The effect of lifetime intake and hepatitis virus infections in men and women","volume":"155","author":"Donato","year":"2002","journal-title":"American Journal of Epidemiology"},{"issue":"48","key":"10.1016\/bs.acr.2020.10.003_bb0265","doi-asserted-by":"crossref","first-page":"32088","DOI":"10.1074\/jbc.273.48.32088","article-title":"Hepatitis C virus glycoprotein complex localization in the endoplasmic reticulum involves a determinant for retention and not retrieval","volume":"273","author":"Duvet","year":"1998","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0270","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajg.2014.04.005","article-title":"Serum complements C3 and C4 in chronic HCV infection and their correlation with response to pegylated interferon and ribavirin treatment","volume":"15","author":"El-Fatah Fahmy Hanno","year":"2014","journal-title":"Arab Journal of Gastroenterology"},{"issue":"10088","key":"10.1016\/bs.acr.2020.10.003_bb0275","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): An open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0280","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.28535","article-title":"Risk of hepatocellular carcinoma after sustained virological response in veterans with hepatitis C virus infection","volume":"64","author":"El-Serag","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2020.10.003_bb0285","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3389\/fimmu.2018.01001","article-title":"The complement system and C1q in chronic hepatitis C virus infection and mixed cryoglobulinemia","volume":"9","author":"El-Shamy","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4254\/wjh.v9.i1.1","article-title":"Disease monitoring of hepatocellular carcinoma through metabolomics","volume":"9","author":"Fitian","year":"2017","journal-title":"World Journal of Hepatology"},{"issue":"7","key":"10.1016\/bs.acr.2020.10.003_bb0295","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1053\/j.gastro.2006.02.060","article-title":"Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein","volume":"130","author":"Furutani","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/bs.acr.2020.10.003_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063818","article-title":"A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection","volume":"8","author":"Gardiner","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/bs.acr.2020.10.003_bb0305","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2893.2010.01362.x","article-title":"Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: Implications for chronic hepatitis C","volume":"18","author":"Gieseler","year":"2011","journal-title":"Journal of Viral Hepatitis"},{"issue":"17","key":"10.1016\/bs.acr.2020.10.003_bb0310","doi-asserted-by":"crossref","first-page":"9599","DOI":"10.1073\/pnas.171311298","article-title":"Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B","volume":"98","author":"Gong","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0315","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3350\/cmh.2015.21.2.105","article-title":"Hepatitis C virus-induced hepatocellular carcinoma","volume":"21","author":"Goossens","year":"2015","journal-title":"Clinical and Molecular Hepatology"},{"issue":"5","key":"10.1016\/bs.acr.2020.10.003_bb0320","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/gutjnl-2014-307990","article-title":"Current concepts of immune based treatments for patients with HCC: From basic science to novel treatment approaches","volume":"64","author":"Greten","year":"2015","journal-title":"Gut"},{"key":"10.1016\/bs.acr.2020.10.003_bb0325","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12935-018-0582-3","article-title":"Long noncoding RNA PVT1 modulates hepatocellular carcinoma cell proliferation and apoptosis by recruiting EZH2","volume":"18","author":"Guo","year":"2018","journal-title":"Cancer Cell International"},{"issue":"8","key":"10.1016\/bs.acr.2020.10.003_bb0330","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"8","key":"10.1016\/bs.acr.2020.10.003_bb0335","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1053\/j.gastro.2019.02.038","article-title":"HCV-induced epigenetic changes associated with liver cancer risk persist after sustained virologic response","volume":"156","author":"Hamdane","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153882","article-title":"Hepatitis C virus protein interaction network analysis based on hepatocellular carcinoma","volume":"11","author":"Han","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.acr.2020.10.003_bb0345","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/liv.13352","article-title":"Intrahepatic angiopoietin-2 correlates with chronic hepatitis C progression and is induced in hepatitis C virus replicon systems","volume":"37","author":"Hernandez-Bartolome","year":"2017","journal-title":"Liver International"},{"issue":"39","key":"10.1016\/bs.acr.2020.10.003_bb0350","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1038\/onc.2012.484","article-title":"Hepatitis C virus-induced activation of beta-catenin promotes c-Myc expression and a cascade of pro-carcinogenetic events","volume":"32","author":"Higgs","year":"2013","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0355","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.celrep.2015.08.077","article-title":"Tumor-expressed IDO recruits and activates MDSCs in a treg-dependent manner","volume":"13","author":"Holmgaard","year":"2015","journal-title":"Cell Reports"},{"issue":"1 Suppl","key":"10.1016\/bs.acr.2020.10.003_bb0360","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.jhep.2014.07.010","article-title":"Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma","volume":"61","author":"Hoshida","year":"2014","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0365","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-017-0643-z","article-title":"Thalassemias in South Asia: Clinical lessons learnt from Bangladesh","volume":"12","author":"Hossain","year":"2017","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0370","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2019.08.014","article-title":"The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications","volume":"72","author":"Hou","year":"2020","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0375","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41598-017-00631-9","article-title":"A circulating MicroRNA signature capable of assessing the risk of hepatocellular carcinoma in cirrhotic patients","volume":"7","author":"Huang","year":"2017","journal-title":"Scientific Reports"},{"issue":"7","key":"10.1016\/bs.acr.2020.10.003_bb0380","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/jgh.13670","article-title":"Diabetes, hepatocellular carcinoma, and mortality in hepatitis C-infected patients: A population-based cohort study","volume":"32","author":"Huang","year":"2017","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"6","key":"10.1016\/bs.acr.2020.10.003_bb0385","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1053\/j.gastro.2003.08.032","article-title":"Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]","volume":"125","author":"Hui","year":"2003","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0390","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/hep.25800","article-title":"The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection","volume":"57","author":"Ioannou","year":"2013","journal-title":"Hepatology"},{"issue":"36","key":"10.1016\/bs.acr.2020.10.003_bb0395","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4254\/wjh.v9.i36.1305","article-title":"Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection","volume":"9","author":"Irshad","year":"2017","journal-title":"World Journal of Hepatology"},{"issue":"3","key":"10.1016\/bs.acr.2020.10.003_bb0400","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.3192","article-title":"The landscape of long noncoding RNAs in the human transcriptome","volume":"47","author":"Iyer","year":"2015","journal-title":"Nature Genetics"},{"issue":"3","key":"10.1016\/bs.acr.2020.10.003_bb0405","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jhep.2016.10.028","article-title":"Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada","volume":"66","author":"Janjua","year":"2017","journal-title":"Journal of Hepatology"},{"issue":"12","key":"10.1016\/bs.acr.2020.10.003_bb0410","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1042\/CBI20110102","article-title":"The oncogenic role of NS5A of hepatitis C virus is mediated by up-regulation of survivin gene expression in the hepatocellular cell through p53 and NF-kappaB pathways","volume":"35","author":"Jiang","year":"2011","journal-title":"Cell Biology International"},{"issue":"5740","key":"10.1016\/bs.acr.2020.10.003_bb0415","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","article-title":"Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA","volume":"309","author":"Jopling","year":"2005","journal-title":"Science"},{"key":"10.1016\/bs.acr.2020.10.003_bb0420","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.trsl.2015.10.002","article-title":"Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma","volume":"168","author":"Kamel","year":"2016","journal-title":"Translational Research"},{"issue":"6","key":"10.1016\/bs.acr.2020.10.003_bb0425","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3390\/ijms20061358","article-title":"Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and C infections: A review","volume":"20","author":"Kanda","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"22","key":"10.1016\/bs.acr.2020.10.003_bb0430","doi-asserted-by":"crossref","first-page":"11066","DOI":"10.1128\/JVI.01300-08","article-title":"Hepatitis C virus core protein augments androgen receptor-mediated signaling","volume":"82","author":"Kanda","year":"2008","journal-title":"Journal of Virology"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0435","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.27095","article-title":"HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. veterans with HCV","volume":"60","author":"Kanwal","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/bs.acr.2020.10.003_bb0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003422","article-title":"Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C","volume":"9","author":"Kared","year":"2013","journal-title":"PLoS Pathogens"},{"issue":"5","key":"10.1016\/bs.acr.2020.10.003_bb0445","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jhep.2008.12.029","article-title":"HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters","volume":"50","author":"Kasai","year":"2009","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1016\/bs.acr.2020.10.003_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007772","article-title":"Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design","volume":"15","author":"Keck","year":"2019","journal-title":"PLoS Pathogens"},{"issue":"12","key":"10.1016\/bs.acr.2020.10.003_bb0455","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/jvh.12576","article-title":"Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection","volume":"23","author":"Keoshkerian","year":"2016","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/bs.acr.2020.10.003_bb0465","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.omtn.2019.01.006","article-title":"Exosomal transmission of MicroRNA from HCV replicating cells stimulates transdifferentiation in hepatic stellate cells","volume":"14","author":"Kim","year":"2019","journal-title":"Molecular Therapy--Nucleic Acids"},{"issue":"10","key":"10.1016\/bs.acr.2020.10.003_bb0460","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3390\/cells8101249","article-title":"Mechanisms underlying hepatitis C virus-associated hepatic fibrosis","volume":"8","author":"Khatun","year":"2019","journal-title":"Cell"},{"issue":"10","key":"10.1016\/bs.acr.2020.10.003_bb0470","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1128\/JVI.00174-13","article-title":"Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function","volume":"87","author":"Kim","year":"2013","journal-title":"Journal of Virology"},{"issue":"Suppl. 1","key":"10.1016\/bs.acr.2020.10.003_bb0475","first-page":"S108","article-title":"Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways","volume":"22","author":"Koike","year":"2007","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"45","key":"10.1016\/bs.acr.2020.10.003_bb0480","doi-asserted-by":"crossref","first-page":"37481","DOI":"10.1074\/jbc.M506412200","article-title":"Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production","volume":"280","author":"Korenaga","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb0485","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jhep.2016.06.009","article-title":"Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment","volume":"65","author":"Kozbial","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb0490","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/QAI.0000000000000494","article-title":"The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection","volume":"68","author":"Kramer","year":"2015","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"6","key":"10.1016\/bs.acr.2020.10.003_bb0495","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/hep.27337","article-title":"Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients","volume":"60","author":"Kruse","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/bs.acr.2020.10.003_bb0500","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng.809","article-title":"Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma","volume":"43","author":"Kumar","year":"2011","journal-title":"Nature Genetics"},{"issue":"22","key":"10.1016\/bs.acr.2020.10.003_bb0505","doi-asserted-by":"crossref","first-page":"11549","DOI":"10.1128\/JVI.01946-15","article-title":"Promotion of cancer stem-like cell properties in hepatitis C virus-infected hepatocytes","volume":"89","author":"Kwon","year":"2015","journal-title":"Journal of Virology"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb0510","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.4049\/jimmunol.1600631","article-title":"Distinct CD55 isoform synthesis and inhibition of complement-dependent cytolysis by hepatitis C virus","volume":"197","author":"Kwon","year":"2016","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.acr.2020.10.003_bb0515","first-page":"977","article-title":"Hepatitis C virus infection: Establishment of chronicity and liver disease progression","volume":"13","author":"Kwon","year":"2014","journal-title":"EXCLI Journal"},{"issue":"21","key":"10.1016\/bs.acr.2020.10.003_bb0520","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01235-17","article-title":"Hepatitis C virus core protein modulates Endoglin (CD105) signaling pathway for Liver pathogenesis","volume":"91","author":"Kwon","year":"2017","journal-title":"Journal of Virology"},{"key":"10.1016\/bs.acr.2020.10.003_bb0525","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.virusres.2015.08.008","article-title":"Regulation of influenza virus infection by long non-coding RNAs","volume":"212","author":"Landeras-Bueno","year":"2016","journal-title":"Virus Research"},{"issue":"Suppl. 1","key":"10.1016\/bs.acr.2020.10.003_bb0530","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1093\/infdis\/jis762","article-title":"Immune responses to hepatitis C virus (HCV) infection and the prospects for an effective HCV vaccine or immunotherapies","volume":"207","author":"Lauer","year":"2013","journal-title":"The Journal of Infectious Diseases"},{"issue":"3","key":"10.1016\/bs.acr.2020.10.003_bb0535","doi-asserted-by":"crossref","first-page":"a036913","DOI":"10.1101\/cshperspect.a036913","article-title":"Hepatitis C virus epidemiology and the impact of interferon-free hepatitis C virus therapy","volume":"10","author":"Lazarus","year":"2020","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"9","key":"10.1016\/bs.acr.2020.10.003_bb0540","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1084\/jem.191.9.1499","article-title":"Analysis of successful immune responses in persons infected with hepatitis C virus","volume":"191","author":"Lechner","year":"2000","journal-title":"The Journal of Experimental Medicine"},{"issue":"7","key":"10.1016\/bs.acr.2020.10.003_bb0545","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ajg.2017.123","article-title":"HCV genotype 6 increased the risk for hepatocellular carcinoma among Asian patients with Liver cirrhosis","volume":"112","author":"Lee","year":"2017","journal-title":"The American Journal of Gastroenterology"},{"issue":"8","key":"10.1016\/bs.acr.2020.10.003_bb0550","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1073\/pnas.0408824102","article-title":"Immune evasion by hepatitis C virus NS3\/4A protease-mediated cleavage of the toll-like receptor 3 adaptor protein TRIF","volume":"102","author":"Li","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"10.1016\/bs.acr.2020.10.003_bb0555","doi-asserted-by":"crossref","first-page":"26087","DOI":"10.3390\/ijms161125942","article-title":"The role of oxidative stress and antioxidants in Liver diseases","volume":"16","author":"Li","year":"2015","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb0560","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2893.1995.tb00031.x","article-title":"Plasma glutathione concentration in patients with chronic hepatitis C virus infection","volume":"2","author":"Lim","year":"1995","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/bs.acr.2020.10.003_bb0565","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-pathol-012414-040323","article-title":"Hepatitis C virus-associated cancer","volume":"10","author":"Lin","year":"2015","journal-title":"Annual Review of Pathology"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb0570","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.tcb.2017.11.008","article-title":"Long noncoding RNA in cancer: Wiring signaling circuitry","volume":"28","author":"Lin","year":"2018","journal-title":"Trends in Cell Biology"},{"issue":"10","key":"10.1016\/bs.acr.2020.10.003_bb0575","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrmicro3098","article-title":"The ins and outs of hepatitis C virus entry and assembly","volume":"11","author":"Lindenbach","year":"2013","journal-title":"Nature Reviews. Microbiology"},{"issue":"26","key":"10.1016\/bs.acr.2020.10.003_bb0580","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.7150\/jca.29213","article-title":"LncRNA MALAT1 acts as a miR-125a-3p sponge to regulate FOXM1 expression and promote hepatocellular carcinoma progression","volume":"10","author":"Liu","year":"2019","journal-title":"Journal of Cancer"},{"issue":"14","key":"10.1016\/bs.acr.2020.10.003_bb0585","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.1128\/JVI.00321-06","article-title":"Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation","volume":"80","author":"Machida","year":"2006","journal-title":"Journal of Virology"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0590","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3748\/wjg.v25.i1.42","article-title":"Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma","volume":"25","author":"Mahmoudvand","year":"2019","journal-title":"World Journal of Gastroenterology"},{"issue":"3","key":"10.1016\/bs.acr.2020.10.003_bb0595","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1128\/JVI.75.3.1401-1407.2001","article-title":"Hepatitis C virus NS5A physically associates with p53 and regulates p21\/waf1 gene expression in a p53-dependent manner","volume":"75","author":"Majumder","year":"2001","journal-title":"Journal of Virology"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0600","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.21672","article-title":"Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma","volume":"46","author":"Matsuzaki","year":"2007","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/bs.acr.2020.10.003_bb0605","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1590\/S0036-46652015000600011","article-title":"Hepatocellular carcinoma in a non-cirrhotic patient with sustained virological response after hepatitis C treatment","volume":"57","author":"Mattos","year":"2015","journal-title":"Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"},{"issue":"14","key":"10.1016\/bs.acr.2020.10.003_bb0610","doi-asserted-by":"crossref","first-page":"7902","DOI":"10.1128\/JVI.00917-13","article-title":"Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles","volume":"87","author":"Mazumdar","year":"2013","journal-title":"Journal of Virology"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb0615","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1128\/JVI.06577-11","article-title":"Hepatitis C virus proteins inhibit C3 complement production","volume":"86","author":"Mazumdar","year":"2012","journal-title":"Journal of Virology"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0620","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/hep.510250142","article-title":"Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis","volume":"25","author":"Mazzanti","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2020.10.003_bb0625","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1146\/annurev.pathol.4.110807.092202","article-title":"Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer","volume":"4","author":"McGivern","year":"2009","journal-title":"Annual Review of Pathology"},{"issue":"3","key":"10.1016\/bs.acr.2020.10.003_bb0630","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.cgh.2016.10.012","article-title":"Infection with hepatitis C virus genotype 3 is an independent risk factor for end-stage liver disease, hepatocellular carcinoma, and liver-related death","volume":"15","author":"McMahon","year":"2017","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"12","key":"10.1016\/bs.acr.2020.10.003_bb0635","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/lt.24959","article-title":"Con: Treating hepatitis C virus with direct-acting antivirals: Fear not the perceived threat of hepatocellular carcinoma","volume":"23","author":"Mehta","year":"2017","journal-title":"Liver Transplantation"},{"issue":"29","key":"10.1016\/bs.acr.2020.10.003_bb0640","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.3748\/wjg.v25.i29.3929","article-title":"Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?","volume":"25","author":"Meringer","year":"2019","journal-title":"World Journal of Gastroenterology"},{"issue":"8","key":"10.1016\/bs.acr.2020.10.003_bb0645","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/jcp.2003.015784","article-title":"Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma","volume":"57","author":"Messerini","year":"2004","journal-title":"Journal of Clinical Pathology"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0650","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.virol.2005.03.016","article-title":"Inhibition of hepatitis C virus core protein expression in immortalized human hepatocytes induces cytochrome c-independent increase in Apaf-1 and caspase-9 activation for cell death","volume":"336","author":"Meyer","year":"2005","journal-title":"Virology"},{"issue":"Suppl. 1","key":"10.1016\/bs.acr.2020.10.003_bb0655","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.jhep.2016.07.012","article-title":"HCV epidemiology in high-risk groups and the risk of reinfection","volume":"65","author":"Midgard","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"8","key":"10.1016\/bs.acr.2020.10.003_bb0660","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ng.876","article-title":"Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers","volume":"43","author":"Miki","year":"2011","journal-title":"Nature Genetics"},{"issue":"3","key":"10.1016\/bs.acr.2020.10.003_bb0665","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI118842","article-title":"Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response","volume":"98","author":"Missale","year":"1996","journal-title":"The Journal of Clinical Investigation"},{"issue":"Suppl. 1","key":"10.1016\/bs.acr.2020.10.003_bb0670","first-page":"91A","article-title":"Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis","volume":"20","author":"Miyakawa","year":"1996","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0675","first-page":"89","article-title":"Implications of the hyperinsulinaemia-diabetes-cancer link for preventive efforts","volume":"7","author":"Moore","year":"1998","journal-title":"European Journal of Cancer Prevention"},{"issue":"17","key":"10.1016\/bs.acr.2020.10.003_bb0680","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2011.02.052","article-title":"Impaired hepatitis B vaccine responses during chronic hepatitis C infection: Involvement of the PD-1 pathway in regulating CD4(+) T cell responses","volume":"29","author":"Moorman","year":"2011","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/bs.acr.2020.10.003_bb0685","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.3748\/wjg.v22.i28.6469","article-title":"Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis","volume":"22","author":"Moreno-Cubero","year":"2016","journal-title":"World Journal of Gastroenterology"},{"issue":"Pt 7","key":"10.1016\/bs.acr.2020.10.003_bb0690","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1099\/0022-1317-78-7-1527","article-title":"Hepatitis C virus core protein induces hepatic steatosis in transgenic mice","volume":"78","author":"Moriya","year":"1997","journal-title":"The Journal of General Virology"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0695","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/j.gastro.2007.11.010","article-title":"Insulin resistance in chronic hepatitis C: Association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis","volume":"134","author":"Moucari","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/bs.acr.2020.10.003_bb0700","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1128\/JVI.03085-14","article-title":"Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK\/STAT signaling pathway","volume":"89","author":"Mukherjee","year":"2015","journal-title":"Journal of Virology"},{"issue":"14","key":"10.1016\/bs.acr.2020.10.003_bb0705","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1128\/JVI.00787-14","article-title":"Transcriptional suppression of miR-181c by hepatitis C virus enhances homeobox A1 expression","volume":"88","author":"Mukherjee","year":"2014","journal-title":"Journal of Virology"},{"issue":"3","key":"10.1016\/bs.acr.2020.10.003_bb0710","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.it.2016.01.002","article-title":"IDO in the tumor microenvironment: Inflammation, counter-regulation, and tolerance","volume":"37","author":"Munn","year":"2016","journal-title":"Trends in Immunology"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0715","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/hep.31298","article-title":"Establishment of a patient-derived xenograft tumor from hepatitis C-associated liver cancer and evaluation of imatinib treatment efficacy","volume":"72","author":"Nazzal","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb0720","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003330","article-title":"IL-1beta production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease","volume":"9","author":"Negash","year":"2013","journal-title":"PLoS Pathogens"},{"key":"10.1016\/bs.acr.2020.10.003_bb0725","first-page":"243","article-title":"Adaptive immune responses in hepatitis C virus infection","volume":"369","author":"Neumann-Haefelin","year":"2013","journal-title":"Current Topics in Microbiology and Immunology"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0730","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","author":"Osburn","year":"2010","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/bs.acr.2020.10.003_bb0735","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/hep.27013","article-title":"Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses","volume":"59","author":"Osburn","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/bs.acr.2020.10.003_bb0740","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00705-013-1892-3","article-title":"Hepatitis C virus nonstructural protein 5A favors upregulation of gluconeogenic and lipogenic gene expression leading towards insulin resistance: A metabolic syndrome","volume":"159","author":"Parvaiz","year":"2014","journal-title":"Archives of Virology"},{"issue":"7","key":"10.1016\/bs.acr.2020.10.003_bb0745","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41419-020-02741-1","article-title":"A combination of AZD5363 and FH5363 induces lethal autophagy in transformed hepatocytes","volume":"11","author":"Patra","year":"2020","journal-title":"Cell Death & Disease"},{"issue":"3","key":"10.1016\/bs.acr.2020.10.003_bb0750","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/hep.30893","article-title":"Hepatitis C virus mediated inhibition of miR-181c activates ATM signaling and promotes hepatocyte growth","volume":"71","author":"Patra","year":"2020","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/bs.acr.2020.10.003_bb0755","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/cells8030274","article-title":"Strategies to circumvent host innate immune response by hepatitis C virus","volume":"8","author":"Patra","year":"2019","journal-title":"Cells"},{"issue":"18","key":"10.1016\/bs.acr.2020.10.003_bb0760","doi-asserted-by":"crossref","first-page":"e00811","DOI":"10.1128\/JVI.00811-19","article-title":"Transforming growth factor beta acts as a regulatory molecule for lipogenic pathways among hepatitis C virus genotype-specific infections","volume":"93","author":"Patra","year":"2019","journal-title":"Journal of Virology"},{"issue":"5","key":"10.1016\/bs.acr.2020.10.003_bb0765","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.chom.2014.10.008","article-title":"Hepatitis C virus RNA replication and assembly: Living on the fat of the land","volume":"16","author":"Paul","year":"2014","journal-title":"Cell Host & Microbe"},{"issue":"Pt 7","key":"10.1016\/bs.acr.2020.10.003_bb0770","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1099\/vir.0.020644-0","article-title":"Hepatitis C virus core protein genotype 3a increases SOCS-7 expression through PPAR-{gamma} in Huh-7 cells","volume":"91","author":"Pazienza","year":"2010","journal-title":"The Journal of General Virology"},{"key":"10.1016\/bs.acr.2020.10.003_bb0775","article-title":"Biology and clinical application of regulatory RNAs in hepatocellular carcinoma","author":"Pea","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2020.10.003_bb0780","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12935-020-01231-w","article-title":"Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a\/PI3K\/Akt\/mTOR axis","volume":"20","author":"Peng","year":"2020","journal-title":"Cancer Cell International"},{"issue":"6","key":"10.1016\/bs.acr.2020.10.003_bb0785","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008181","article-title":"Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals","volume":"15","author":"Perez","year":"2019","journal-title":"PLoS Genetics"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0790","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1096\/fj.01-0396com","article-title":"Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: A model of viral-related steatosis","volume":"16","author":"Perlemuter","year":"2002","journal-title":"The FASEB Journal"},{"issue":"10","key":"10.1016\/bs.acr.2020.10.003_bb0795","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1515\/CCLM.2009.280","article-title":"SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cells","volume":"47","author":"Persico","year":"2009","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"issue":"14","key":"10.1016\/bs.acr.2020.10.003_bb0800","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.acr.2020.10.003_bb0805","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3389\/fimmu.2019.00774","article-title":"Complementing the cancer-immunity cycle","volume":"10","author":"Pio","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.acr.2020.10.003_bb0810","first-page":"673","article-title":"Cancer immunotherapy by targeting IDO1\/TDO and their downstream effectors","volume":"5","author":"Platten","year":"2014","journal-title":"Frontiers in Immunology"},{"issue":"11","key":"10.1016\/bs.acr.2020.10.003_bb0815","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/v10110591","article-title":"Non-coding RNAs and hepatitis C virus-induced hepatocellular carcinoma","volume":"10","author":"Plissonnier","year":"2018","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/bs.acr.2020.10.003_bb0820","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00262-014-1549-4","article-title":"Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer","volume":"63","author":"Prendergast","year":"2014","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0825","doi-asserted-by":"crossref","first-page":"9","DOI":"10.14218\/JCTH.2015.00001","article-title":"Diabetes mellitus predicts occurrence of cirrhosis and hepatocellular cancer in alcoholic liver and non-alcoholic fatty liver diseases","volume":"3","author":"Raff","year":"2015","journal-title":"Journal of Clinical and Translational Hepatology"},{"issue":"6","key":"10.1016\/bs.acr.2020.10.003_bb0830","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1128\/JVI.02862-13","article-title":"Activity of hexokinase is increased by its interaction with hepatitis C virus protein NS5A","volume":"88","author":"Ramiere","year":"2014","journal-title":"Journal of Virology"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0835","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgw118","article-title":"Frequently mutated genes\/pathways and genomic instability as prevention targets in liver cancer","volume":"38","author":"Rao","year":"2017","journal-title":"Carcinogenesis"},{"issue":"13","key":"10.1016\/bs.acr.2020.10.003_bb0840","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1073\/pnas.121145898","article-title":"The target of rapamycin (TOR) proteins","volume":"98","author":"Raught","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0845","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/hep.30214","article-title":"Hepatitis C virus manipulates humans as its favorite host for a long-term relationship","volume":"69","author":"Ray","year":"2019","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/bs.acr.2020.10.003_bb0850","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nm.3251","article-title":"Pathogenesis of chronic viral hepatitis: Differential roles of T cells and NK cells","volume":"19","author":"Rehermann","year":"2013","journal-title":"Nature Medicine"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb0855","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","article-title":"Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy","volume":"65","author":"Reig","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1016\/bs.acr.2020.10.003_bb0860","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-biochem-051410-092902","article-title":"Genome regulation by long noncoding RNAs","volume":"81","author":"Rinn","year":"2012","journal-title":"Annual Review of Biochemistry"},{"issue":"Suppl. 1","key":"10.1016\/bs.acr.2020.10.003_bb0865","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/liv.13659","article-title":"The impact of treatment of hepatitis C with DAAs on the occurrence of HCC","volume":"38","author":"Roche","year":"2018","journal-title":"Liver International"},{"issue":"6","key":"10.1016\/bs.acr.2020.10.003_bb0870","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/med.21452","article-title":"Tumor angiogenesis revisited: Regulators and clinical implications","volume":"37","author":"Ronca","year":"2017","journal-title":"Medicinal Research Reviews"},{"issue":"11","key":"10.1016\/bs.acr.2020.10.003_bb0875","first-page":"745","article-title":"Surveillance for hepatocellular carcinoma","volume":"10","author":"Saab","year":"2014","journal-title":"Gastroenterolog\u00eda y Hepatolog\u00eda"},{"issue":"8","key":"10.1016\/bs.acr.2020.10.003_bb0880","doi-asserted-by":"crossref","first-page":"12188","DOI":"10.1002\/jcp.27956","article-title":"microRNAs: Key players in virus-associated hepatocellular carcinoma","volume":"234","author":"Sadri Nahand","year":"2019","journal-title":"Journal of Cellular Physiology"},{"issue":"46","key":"10.1016\/bs.acr.2020.10.003_bb0885","doi-asserted-by":"crossref","first-page":"43799","DOI":"10.1074\/jbc.M207160200","article-title":"Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways","volume":"277","author":"Sanchez-Elsner","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/bs.acr.2020.10.003_bb0890","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.29170","article-title":"Hepatitis C virus-induced CCL5 secretion from macrophages activates hepatic stellate cells","volume":"66","author":"Sasaki","year":"2017","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/bs.acr.2020.10.003_bb0895","doi-asserted-by":"crossref","first-page":"898","DOI":"10.4254\/wjh.v10.i12.898","article-title":"Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response","volume":"10","author":"Sasaki","year":"2018","journal-title":"World Journal of Hepatology"},{"issue":"7","key":"10.1016\/bs.acr.2020.10.003_bb0900","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep4.1362","article-title":"Repression of MicroRNA-30e by hepatitis C virus enhances fatty acid synthesis","volume":"3","author":"Sasaki","year":"2019","journal-title":"Hepatology Communications"},{"issue":"3","key":"10.1016\/bs.acr.2020.10.003_bb0905","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0168-8278(00)00036-2","article-title":"Hepatitis C virus induced hypobetalipoproteinemia: A possible mechanism for steatosis in chronic hepatitis C","volume":"34","author":"Serfaty","year":"2001","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1016\/bs.acr.2020.10.003_bb0910","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1365-2893.2002.00373.x","article-title":"Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees","volume":"9","author":"Shata","year":"2002","journal-title":"Journal of Viral Hepatitis"},{"issue":"6","key":"10.1016\/bs.acr.2020.10.003_bb0915","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/hep.22269","article-title":"Hepatitis C virus infection: Molecular pathways to metabolic syndrome","volume":"47","author":"Sheikh","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0920","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/viro.2001.1225","article-title":"Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins","volume":"292","author":"Shi","year":"2002","journal-title":"Virology"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0925","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4049\/jimmunol.1302069","article-title":"KLRG1 impairs CD4+ T cell responses via p16ink4a and p27kip1 pathways: Role in hepatitis B vaccine failure in individuals with hepatitis C virus infection","volume":"192","author":"Shi","year":"2014","journal-title":"Journal of Immunology"},{"issue":"3","key":"10.1016\/bs.acr.2020.10.003_bb0930","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2169\/internalmedicine.56.7002","article-title":"The serum oxidative\/anti-oxidative stress balance becomes dysregulated in patients with non-alcoholic steatohepatitis associated with hepatocellular carcinoma","volume":"56","author":"Shimomura","year":"2017","journal-title":"Internal Medicine"},{"issue":"22","key":"10.1016\/bs.acr.2020.10.003_bb0935","doi-asserted-by":"crossref","first-page":"12284","DOI":"10.1128\/JVI.01962-13","article-title":"Hepatitis C virus induces interleukin-1beta (IL-1beta)\/IL-18 in circulatory and resident liver macrophages","volume":"87","author":"Shrivastava","year":"2013","journal-title":"Journal of Virology"},{"issue":"3","key":"10.1016\/bs.acr.2020.10.003_bb0940","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.26296","article-title":"Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression","volume":"58","author":"Shrivastava","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0945","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gendis.2015.01.001","article-title":"MicroRNAs: Role in hepatitis C virus pathogenesis","volume":"2","author":"Shrivastava","year":"2015","journal-title":"Genes & Diseases"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0950","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7326\/0003-4819-116-2-97","article-title":"Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study","volume":"116","author":"Simonetti","year":"1992","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb0955","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1128\/JVI.01581-07","article-title":"Spontaneous recovery in acute human hepatitis C virus infection: Functional T-cell thresholds and relative importance of CD4 help","volume":"82","author":"Smyk-Pearson","year":"2008","journal-title":"Journal of Virology"},{"issue":"43","key":"10.1016\/bs.acr.2020.10.003_bb0960","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1038\/onc.2011.621","article-title":"Long non-coding RNAs and cancer: A new frontier of translational research?","volume":"31","author":"Spizzo","year":"2012","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb0965","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.virol.2010.12.045","article-title":"Complement and viral pathogenesis","volume":"411","author":"Stoermer","year":"2011","journal-title":"Virology"},{"issue":"24","key":"10.1016\/bs.acr.2020.10.003_bb0970","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1073\/pnas.202608199","article-title":"Genomic analysis of the host response to hepatitis C virus infection","volume":"99","author":"Su","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"20","key":"10.1016\/bs.acr.2020.10.003_bb0975","doi-asserted-by":"crossref","first-page":"e01215","DOI":"10.1128\/JVI.01215-18","article-title":"Association between MicroRNA-373 and Long noncoding RNA NORAD in hepatitis C virus-infected hepatocytes impairs Wee1 expression for growth promotion","volume":"92","author":"Sur","year":"2018","journal-title":"Journal of Virology"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb0980","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tem.2009.07.005","article-title":"Hepatitis C virus hijacks host lipid metabolism","volume":"21","author":"Syed","year":"2010","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"5","key":"10.1016\/bs.acr.2020.10.003_bb0985","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/75063","article-title":"Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C","volume":"6","author":"Takaki","year":"2000","journal-title":"Nature Medicine"},{"issue":"7","key":"10.1016\/bs.acr.2020.10.003_bb0990","doi-asserted-by":"crossref","first-page":"968","DOI":"10.4254\/wjh.v7.i7.968","article-title":"Control of oxidative stress in hepatocellular carcinoma: Helpful or harmful?","volume":"7","author":"Takaki","year":"2015","journal-title":"World Journal of Hepatology"},{"issue":"15","key":"10.1016\/bs.acr.2020.10.003_bb0995","doi-asserted-by":"crossref","first-page":"7453","DOI":"10.1128\/JVI.76.15.7453-7459.2002","article-title":"Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway","volume":"76","author":"Tardif","year":"2002","journal-title":"Journal of Virology"},{"key":"10.1016\/bs.acr.2020.10.003_bb1000","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.biopha.2018.03.105","article-title":"Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma","volume":"102","author":"Toraih","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb1005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1084\/jem.20011145","article-title":"Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions","volume":"195","author":"Tseng","year":"2002","journal-title":"The Journal of Experimental Medicine"},{"issue":"2","key":"10.1016\/bs.acr.2020.10.003_bb1010","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/jcp.20592","article-title":"Regulation of Ang2 release by PTEN\/PI3-kinase\/Akt in lung microvascular endothelial cells","volume":"207","author":"Tsigkos","year":"2006","journal-title":"Journal of Cellular Physiology"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb1015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/hep.21242","article-title":"Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses","volume":"44","author":"Urbani","year":"2006","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/bs.acr.2020.10.003_bb1020","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jacc.2011.06.068","article-title":"Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy","volume":"58","author":"van de Veerdonk","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"10.1016\/bs.acr.2020.10.003_bb1025","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/gutjnl-2016-312270","article-title":"miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis","volume":"67","author":"Van Renne","year":"2018","journal-title":"Gut"},{"issue":"10","key":"10.1016\/bs.acr.2020.10.003_bb1030","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.cmi.2016.07.019","article-title":"Molecular mechanisms of hepatitis C virus-induced hepatocellular carcinoma","volume":"22","author":"Vescovo","year":"2016","journal-title":"Clinical Microbiology and Infection"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb1035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010049","article-title":"Molecular mechanisms involved in HCC recurrence after direct-acting antiviral therapy","volume":"20","author":"Villani","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"15","key":"10.1016\/bs.acr.2020.10.003_bb1040","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1016\/bs.acr.2020.10.003_bb1045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3851\/IMP1987","article-title":"Angiogenic activity of hepatitis B and C viruses","volume":"22","author":"Vrancken","year":"2012","journal-title":"Antiviral Chemistry & Chemotherapy"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb1050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12943-019-1086-z","article-title":"The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma","volume":"18","author":"Wei","year":"2019","journal-title":"Molecular Cancer"},{"key":"10.1016\/bs.acr.2020.10.003_bb1055","doi-asserted-by":"crossref","first-page":"11623","DOI":"10.2147\/OTT.S218308","article-title":"Long non-coding RNA EGOT promotes the malignant phenotypes of hepatocellular carcinoma cells and increases the expression of HMGA2 via down-regulating miR-33a-5p","volume":"12","author":"Wu","year":"2019","journal-title":"Oncotargets and Therapy"},{"issue":"43","key":"10.1016\/bs.acr.2020.10.003_bb1060","doi-asserted-by":"crossref","first-page":"29396","DOI":"10.1074\/jbc.M802821200","article-title":"Hepatitis C virus NS5A protein down-regulates the expression of spindle gene Aspm through PKR-p38 signaling pathway","volume":"283","author":"Wu","year":"2008","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/bs.acr.2020.10.003_bb1065","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00432-017-2370-1","article-title":"Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression","volume":"143","author":"Xiao","year":"2017","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"5","key":"10.1016\/bs.acr.2020.10.003_bb1070","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/hep.22508","article-title":"Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production","volume":"48","author":"Yang","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb1075","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jhep.2016.08.016","article-title":"Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?","volume":"66","author":"Zavaglia","year":"2017","journal-title":"Journal of Hepatology"},{"issue":"9","key":"10.1016\/bs.acr.2020.10.003_bb1080","doi-asserted-by":"crossref","first-page":"12273","DOI":"10.1007\/s13277-016-5097-8","article-title":"Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection","volume":"37","author":"Zekri","year":"2016","journal-title":"Tumour Biology"},{"issue":"5","key":"10.1016\/bs.acr.2020.10.003_bb1085","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/hep.25849","article-title":"Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/bs.acr.2020.10.003_bb1090","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3233\/CBM-170727","article-title":"lncRNA-HEIH in serum and exosomes as a potential biomarker in the HCV-related hepatocellular carcinoma","volume":"21","author":"Zhang","year":"2018","journal-title":"Cancer Biomarkers"},{"issue":"41","key":"10.1016\/bs.acr.2020.10.003_bb1095","doi-asserted-by":"crossref","first-page":"43770","DOI":"10.18632\/oncotarget.6087","article-title":"Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/bs.acr.2020.10.003_bb1100","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.2147\/OTT.S205169","article-title":"MiRNA-124 inhibits the proliferation, migration and invasion of cancer cell in hepatocellular carcinoma by downregulating lncRNA-UCA1","volume":"12","author":"Zhao","year":"2019","journal-title":"Oncotargets and Therapy"},{"issue":"1","key":"10.1016\/bs.acr.2020.10.003_bb1105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13148-019-0733-y","article-title":"DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma","volume":"11","author":"Zheng","year":"2019","journal-title":"Clinical Epigenetics"},{"issue":"7","key":"10.1016\/bs.acr.2020.10.003_bb1110","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S1470-2045(18)30351-6","article-title":"Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): A non-randomised, open-label phase 2 trial","volume":"19","author":"Zhu","year":"2018","journal-title":"The Lancet Oncology"}],"container-title":["Advances in Cancer Research","Mechanisms and Therapy of Liver Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X20300695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X20300695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:14:06Z","timestamp":1758741246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065230X20300695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780128240304"],"references-count":221,"URL":"https:\/\/doi.org\/10.1016\/bs.acr.2020.10.003","relation":{},"ISSN":["0065-230X"],"issn-type":[{"value":"0065-230X","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}